期刊文献+

高级别宫颈鳞状上皮内瘤变锥切手术前后阴道菌群比较研究 被引量:12

Diversity analysis of the vaginal microbiota before and after cervical conization in women with HSIL
原文传递
导出
摘要 目的探讨高级别宫颈鳞状上皮内瘤变(HSIL)锥切手术前后阴道菌群构成的差异。方法选择2015年12月至2016年8月南方医科大学珠江医院、广东省人民医院收治的HSIL患者20例,分别采集其锥切手术前与手术后3个月的阴道分泌物,同时检测高危型HPV-DNA含量(HC2法);随后对每个样本进行细菌总基因组DNA提取、16S rRNA V4区基因扩增及采用Illumina高通量测序技术对扩增的PCR产物进行测序等步骤,然后通过BIPES生物信息分析方法比较HSIL患者手术前后阴道菌群物种丰度和结构的差异。结果 HSIL患者术前高危型HPV-DNA均为阳性,术后3个月第1次复查均转阴性。HSIL患者手术前的阴道菌群以惰性乳酸杆菌、加德纳菌属、普氏菌属、奇异菌属等为优势菌属,而卷曲乳酸杆菌含量低。在锥切手术后,惰性乳酸杆菌、加德纳菌属、普氏菌属、奇异菌属等则明显降低,卷曲乳酸杆菌则有升高趋势。术后则以卷曲乳酸杆菌、脲原体、普氏菌属、肠球菌属等为优势菌属。结论高级别宫颈鳞状上皮内瘤变患者经手术去除病变后,高危型HPV含量显著减少甚至消失,其阴道菌群出现了向常见阴道优势菌属转变的趋势。提示HPV可能与阴道菌群构成密切相关且相互影响。 Objective To explore the diversity of the vaginal flora before and after cervical conization in patients with high-grade squamous intraepithelial lesion(HSIL). Methods Swabs were collected from December 2015 to August 2016 in Guangdong General Hospital and Zhujiang Hospital from 20 cases of HSIL patients before cervical conization and three months after cervical conization. Microbiota composition,alpha diversity and beta diversity among two groups were determined by analyzing the 16 S rRNA V4 hypervariable region amplified from total genomic DNA prepared from the swabs.Results L.iners,Gardnerella,Prevotella and Atopobium was the predominant species in HSIL patients before cervical conization,and the content of L.crispatus decreased significantly.While after cervical conization,content of L.iners,Gardnerella,Prevotella and Atopobium decreased,while content of L.crispatus increased.Conclusion High abundant of L.iners,Gardnerella,Prevotella and Atopobium and low abundant of L.crispatus maybe was the risk factors of HR-HPV infection.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2017年第9期949-954,共6页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 高级别宫颈鳞状上皮内瘤变 阴道菌群 BIPES 16S RRNA high-grade squamous intraepithelial lesion vaginal flora BIPES 16S rRNA
  • 相关文献

参考文献1

二级参考文献40

  • 1Sobel JD. Vulvovaginal candidiasis [J].Lancet,2007,369(9577): 1961-1971.
  • 2Li L, Bedding S, Dongari-Bagtzoglou A. Candida glabrata: an emerging oral opportunistic pathogen [ J ]. J Dent Res, 2007,86 (3) :204-215.
  • 3Marichal P, vanden Bossohe H, Odds FC, et al. Molecular bio- logical characterization of an azole-resistant Candida glablata isolate [J]. Antimicrob Agents Chemother, 1997, 41(10):2229- 2237.
  • 4Morio F, Loge C, Besse B, et al. Screening for amino acid substi- tutions in the Candida albicans Ergl 1 protein of azole-suscepti- ble and azole-resistant clinical isolates: new substitutions and a review of the literature [J]. Diagn Microbiol Infect Dis, 2010,66 (4): 373-384.
  • 5White TC. The presence of an R467K amino acid substitution and loss of allelie variation correlate with an azole-resistant la- nosterol 14alpha demethylase in Candida albicans [J]. Antimi- crob Agents Chemother, 1997, 41(7): 1488-1494.
  • 6Sanglard D, Ischer F, Koymans L, et al. Amino acid substitution in the cytochrome P- 450 lanosterol 14a- demethylase (CYP51A1) from azole-resistant Candida albicans clinical iso- lates contribute to resistance to azole antifungal agents [J ]. Anti- microb Agents Chemothcr, 1998, 42(2) : 241-253.
  • 7Morio F, Loge C, Besse B, et al. Screening for amino acid substi- tutions in the Candida albicans Ergl 1 protein of azole-suscepti- ble and azole-resistant clinical isolates: new substitutions and a review of the literature [J]. Diagn Microbiol Infect Dis,2010, 66 (4):373-384.
  • 8Mariehal P, vanden Bossche H, Odds FC, et al. Molecular bio- logieal characterization of an azole-resistant Candida glabla- ta[J]. Antimicrob Agents Chemother, 1997,41(10):2229-2237.
  • 9Lamb DC, Maspahy S, Kelly DE, et al. Purification, reconstitu- tion, and inhibition of cytochrome P-450 sterol delta22-desatu- rase from the pathogenie fungus Candida glabrata [J].Antimi- crob Agents Chemother, 1999,43(7):1725-1728.
  • 10Martel CM, Parker JE, Bader O, et al. A clinical isolate of Can- dida albicans with mutations in ERG11 (encoding sterol 14al- pha- demethylase) and ERG5 (encoding C22 desaturase) is cross resistant to azoles and amphotericin B [J].Antimicrob Agents Chemother,2010, 54(9):3578-3583.

共引文献12

同被引文献92

引证文献12

二级引证文献103

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部